Oramed receives ~$1M prepayment on Scilex Tranche A Note; outstanding reduced to $80.2M

ORAMED PHARMACEUTICALS INC.

Received ~$1,000,000 mandatory prepayment on Tranche A Note from Scilex on Oct 24, 2024.
After payment, $80,200,000 of original $101.875M principal repaid or refinanced.
Payment represents 70% of net cash proceeds from Scilex debt/equity financings.
Original Tranche A Note issued Sep 2023; $22.5M exchanged for Tranche B Notes in Oct 2024.
$2.5M of principal exchanged for royalty purchase agreement interest.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.